16/03/2026
🦷 “Zygoma Implant Therapy: Setting the Standard for Atrophic Maxilla?” at Edentulism Conference 2025 with Dr. Rubén Davó
Dr. Rubén Davó took the audience through the evolution of zygomatic implant therapy, from the early controversial years to today’s reality of long-term data, immediate function protocols, and increasingly refined surgical planning.
He explored the big clinical question behind the lecture: in cases of severe maxillary atrophy, could quad zygoma move from being an alternative to becoming the reference benchmark, especially when time to function and patient outcomes are prioritised?
One statement captured the patient-centred impact of immediate function: “We don't improve the quality of life, we normalise the quality of life.” - Dr. Rubén Davó at Edentulism Conference 2025.
A powerful reminder that for edentulous patients, predictable function and restored confidence are not optional; they are the goal.